On April 30, 2020, Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, announced that it closed a $50 million Series B financing led by Frazier Healthcare Partners with participation from Longitude Capital, existing investor Euclidean Capital, and an undisclosed investor. Wilson Sonsini Goodrich & Rosati represented Dascena in the transaction.

The Series B financing will enable Dascena to advance a suite of machine learning algorithms to inform patient care strategies and improve outcomes. Dascena algorithms have been validated through eighteen peer-reviewed publications in several studies funded by the National Institutes of Health and the National Science Foundation.

The Wilson Sonsini team that represented Dascena in the transaction includes James Huie, Ian Edvalson, David Hoffmeister, Ali Alemozafar, Matt Staples, Myra Sutanto Shen, Michael Klippert, Haley Bavasi, Eva Yin, Miruna Predescu, Mary O’Brien, and Jacie Valentine.

For more information, please see Dascena’s press release.